CN101684174A - 两亲性可生物降解聚酯梳型接枝共聚物及其温敏原位凝胶体系 - Google Patents
两亲性可生物降解聚酯梳型接枝共聚物及其温敏原位凝胶体系 Download PDFInfo
- Publication number
- CN101684174A CN101684174A CN200910143234A CN200910143234A CN101684174A CN 101684174 A CN101684174 A CN 101684174A CN 200910143234 A CN200910143234 A CN 200910143234A CN 200910143234 A CN200910143234 A CN 200910143234A CN 101684174 A CN101684174 A CN 101684174A
- Authority
- CN
- China
- Prior art keywords
- comb
- methyl
- polyester
- grafted copolymer
- copolymer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920001577 copolymer Polymers 0.000 title claims abstract description 80
- 229920000728 polyester Polymers 0.000 title claims abstract description 70
- 239000003814 drug Substances 0.000 claims abstract description 55
- 230000002209 hydrophobic effect Effects 0.000 claims abstract description 21
- 238000002360 preparation method Methods 0.000 claims abstract description 19
- 229920000642 polymer Polymers 0.000 claims abstract description 17
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 17
- JJTUDXZGHPGLLC-UHFFFAOYSA-N lactide Chemical compound CC1OC(=O)C(C)OC1=O JJTUDXZGHPGLLC-UHFFFAOYSA-N 0.000 claims abstract description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 16
- 150000002596 lactones Chemical class 0.000 claims abstract description 14
- 229920001519 homopolymer Polymers 0.000 claims abstract description 12
- -1 polyethylene Polymers 0.000 claims abstract description 10
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims abstract description 4
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 4
- 229920001223 polyethylene glycol Polymers 0.000 claims description 31
- 229940079593 drug Drugs 0.000 claims description 27
- 229910052757 nitrogen Inorganic materials 0.000 claims description 25
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 claims description 20
- 239000007864 aqueous solution Substances 0.000 claims description 19
- 239000000203 mixture Substances 0.000 claims description 18
- 239000000178 monomer Substances 0.000 claims description 17
- 229920002521 macromolecule Polymers 0.000 claims description 16
- 239000003999 initiator Substances 0.000 claims description 14
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 12
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 12
- 239000006185 dispersion Substances 0.000 claims description 12
- 125000005395 methacrylic acid group Chemical group 0.000 claims description 12
- 239000002202 Polyethylene glycol Substances 0.000 claims description 11
- 239000007788 liquid Substances 0.000 claims description 11
- BDLFEAFWNOROAK-UHFFFAOYSA-N 2,3-bis(hydroxymethyl)-4-methylphenol Chemical compound CC1=CC=C(O)C(CO)=C1CO BDLFEAFWNOROAK-UHFFFAOYSA-N 0.000 claims description 10
- 238000010560 atom transfer radical polymerization reaction Methods 0.000 claims description 8
- 229920000578 graft copolymer Polymers 0.000 claims description 8
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 8
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 7
- 241001465754 Metazoa Species 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 6
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 6
- 229910052794 bromium Inorganic materials 0.000 claims description 6
- 125000001246 bromo group Chemical group Br* 0.000 claims description 6
- 238000000502 dialysis Methods 0.000 claims description 6
- 229960004194 lidocaine Drugs 0.000 claims description 6
- YPHQUSNPXDGUHL-UHFFFAOYSA-N n-methylprop-2-enamide Chemical compound CNC(=O)C=C YPHQUSNPXDGUHL-UHFFFAOYSA-N 0.000 claims description 6
- 238000006116 polymerization reaction Methods 0.000 claims description 6
- 230000008569 process Effects 0.000 claims description 6
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 6
- 230000007704 transition Effects 0.000 claims description 6
- 125000004423 acyloxy group Chemical group 0.000 claims description 5
- 238000006243 chemical reaction Methods 0.000 claims description 5
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 5
- 239000003643 water by type Substances 0.000 claims description 5
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 claims description 4
- 102000004190 Enzymes Human genes 0.000 claims description 4
- 108090000790 Enzymes Proteins 0.000 claims description 4
- 239000000654 additive Substances 0.000 claims description 4
- SMZOGRDCAXLAAR-UHFFFAOYSA-N aluminium isopropoxide Chemical compound [Al+3].CC(C)[O-].CC(C)[O-].CC(C)[O-] SMZOGRDCAXLAAR-UHFFFAOYSA-N 0.000 claims description 4
- 238000004113 cell culture Methods 0.000 claims description 4
- 238000001514 detection method Methods 0.000 claims description 4
- 230000009969 flowable effect Effects 0.000 claims description 4
- 229920001184 polypeptide Polymers 0.000 claims description 4
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 4
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 4
- 102000004169 proteins and genes Human genes 0.000 claims description 4
- PAPBSGBWRJIAAV-UHFFFAOYSA-N ε-Caprolactone Chemical compound O=C1CCCCCO1 PAPBSGBWRJIAAV-UHFFFAOYSA-N 0.000 claims description 4
- 229910021589 Copper(I) bromide Inorganic materials 0.000 claims description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 3
- 238000013019 agitation Methods 0.000 claims description 3
- 210000001124 body fluid Anatomy 0.000 claims description 3
- 239000010839 body fluid Substances 0.000 claims description 3
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims description 3
- 230000001900 immune effect Effects 0.000 claims description 3
- COYVWKMZTCAFHO-UHFFFAOYSA-N n-methyl-n-propan-2-ylprop-2-enamide Chemical compound CC(C)N(C)C(=O)C=C COYVWKMZTCAFHO-UHFFFAOYSA-N 0.000 claims description 3
- 230000004044 response Effects 0.000 claims description 3
- 238000007789 sealing Methods 0.000 claims description 3
- 238000013268 sustained release Methods 0.000 claims description 3
- 239000012730 sustained-release form Substances 0.000 claims description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 2
- RKDVKSZUMVYZHH-UHFFFAOYSA-N 1,4-dioxane-2,5-dione Chemical compound O=C1COC(=O)CO1 RKDVKSZUMVYZHH-UHFFFAOYSA-N 0.000 claims description 2
- 230000000996 additive effect Effects 0.000 claims description 2
- 229910052786 argon Inorganic materials 0.000 claims description 2
- 229940088623 biologically active substance Drugs 0.000 claims description 2
- 210000004369 blood Anatomy 0.000 claims description 2
- 239000008280 blood Substances 0.000 claims description 2
- 238000007334 copolymerization reaction Methods 0.000 claims description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 2
- 239000007789 gas Substances 0.000 claims description 2
- 238000012637 gene transfection Methods 0.000 claims description 2
- 239000007972 injectable composition Substances 0.000 claims description 2
- QRWZCJXEAOZAAW-UHFFFAOYSA-N n,n,2-trimethylprop-2-enamide Chemical compound CN(C)C(=O)C(C)=C QRWZCJXEAOZAAW-UHFFFAOYSA-N 0.000 claims description 2
- OVHHHVAVHBHXAK-UHFFFAOYSA-N n,n-diethylprop-2-enamide Chemical compound CCN(CC)C(=O)C=C OVHHHVAVHBHXAK-UHFFFAOYSA-N 0.000 claims description 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 2
- 238000007151 ring opening polymerisation reaction Methods 0.000 claims description 2
- 238000007142 ring opening reaction Methods 0.000 claims description 2
- 238000001727 in vivo Methods 0.000 abstract description 6
- 238000012377 drug delivery Methods 0.000 abstract description 5
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 abstract description 4
- 231100000252 nontoxic Toxicity 0.000 abstract description 2
- 230000003000 nontoxic effect Effects 0.000 abstract description 2
- 230000035699 permeability Effects 0.000 abstract description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 abstract 3
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 abstract 1
- 239000004698 Polyethylene Substances 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- 239000007857 degradation product Substances 0.000 abstract 1
- 229920000573 polyethylene Polymers 0.000 abstract 1
- 239000012096 transfection reagent Substances 0.000 abstract 1
- 239000000499 gel Substances 0.000 description 50
- 229920001610 polycaprolactone Polymers 0.000 description 34
- 229920002246 poly[2-(dimethylamino)ethyl methacrylate] polymer Polymers 0.000 description 19
- JKNCOURZONDCGV-UHFFFAOYSA-N 2-(dimethylamino)ethyl 2-methylprop-2-enoate Chemical compound CN(C)CCOC(=O)C(C)=C JKNCOURZONDCGV-UHFFFAOYSA-N 0.000 description 18
- 239000004632 polycaprolactone Substances 0.000 description 17
- 239000003795 chemical substances by application Substances 0.000 description 16
- 230000008859 change Effects 0.000 description 14
- 239000002105 nanoparticle Substances 0.000 description 11
- 239000002953 phosphate buffered saline Substances 0.000 description 11
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 8
- 239000002245 particle Substances 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 239000000693 micelle Substances 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 229930012538 Paclitaxel Natural products 0.000 description 6
- 229960001592 paclitaxel Drugs 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 5
- 229960002949 fluorouracil Drugs 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000011065 in-situ storage Methods 0.000 description 4
- 239000013612 plasmid Substances 0.000 description 4
- 101150036326 PMT2 gene Proteins 0.000 description 3
- 229920000436 Poly(lactide-co-glycolide)-block-poly(ethylene glycol)-block-poly(lactide-co-glycolide) Polymers 0.000 description 3
- 229920001273 Polyhydroxy acid Polymers 0.000 description 3
- 101100241858 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OAC1 gene Proteins 0.000 description 3
- 101100043108 Schizosaccharomyces pombe (strain 972 / ATCC 24843) spb1 gene Proteins 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 229920000229 biodegradable polyester Polymers 0.000 description 3
- 239000004622 biodegradable polyester Substances 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 229920001400 block copolymer Polymers 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000001879 gelation Methods 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 239000008176 lyophilized powder Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 101150092906 pmt1 gene Proteins 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 150000005846 sugar alcohols Polymers 0.000 description 3
- GNWBLLYJQXKPIP-ZOGIJGBBSA-N (1s,3as,3bs,5ar,9ar,9bs,11as)-n,n-diethyl-6,9a,11a-trimethyl-7-oxo-2,3,3a,3b,4,5,5a,8,9,9b,10,11-dodecahydro-1h-indeno[5,4-f]quinoline-1-carboxamide Chemical compound CN([C@@H]1CC2)C(=O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H](C(=O)N(CC)CC)[C@@]2(C)CC1 GNWBLLYJQXKPIP-ZOGIJGBBSA-N 0.000 description 2
- YEJRWHAVMIAJKC-UHFFFAOYSA-N 4-Butyrolactone Chemical compound O=C1CCCO1 YEJRWHAVMIAJKC-UHFFFAOYSA-N 0.000 description 2
- OZJPLYNZGCXSJM-UHFFFAOYSA-N 5-valerolactone Chemical compound O=C1CCCCO1 OZJPLYNZGCXSJM-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 230000001186 cumulative effect Effects 0.000 description 2
- 238000013016 damping Methods 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000006073 displacement reaction Methods 0.000 description 2
- 238000001647 drug administration Methods 0.000 description 2
- 235000021050 feed intake Nutrition 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 239000000017 hydrogel Substances 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 239000002539 nanocarrier Substances 0.000 description 2
- 229920001983 poloxamer Polymers 0.000 description 2
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 description 2
- 229920001513 poly[2-(diethylamino)ethyl methacrylate] polymer Polymers 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 238000001890 transfection Methods 0.000 description 2
- JHPBZFOKBAGZBL-UHFFFAOYSA-N (3-hydroxy-2,2,4-trimethylpentyl) 2-methylprop-2-enoate Chemical compound CC(C)C(O)C(C)(C)COC(=O)C(C)=C JHPBZFOKBAGZBL-UHFFFAOYSA-N 0.000 description 1
- BTLMAMNOWQEAQM-UHFFFAOYSA-N 2-hydroxybutanoic acid;2-hydroxypropanoic acid Chemical compound CC(O)C(O)=O.CCC(O)C(O)=O BTLMAMNOWQEAQM-UHFFFAOYSA-N 0.000 description 1
- SJZRECIVHVDYJC-UHFFFAOYSA-N 4-hydroxybutyric acid Chemical compound OCCCC(O)=O SJZRECIVHVDYJC-UHFFFAOYSA-N 0.000 description 1
- ROFVEXUMMXZLPA-UHFFFAOYSA-N Bipyridyl Chemical compound N1=CC=CC=C1C1=CC=CC=N1 ROFVEXUMMXZLPA-UHFFFAOYSA-N 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 1
- 229920006022 Poly(L-lactide-co-glycolide)-b-poly(ethylene glycol) Polymers 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 229920000469 amphiphilic block copolymer Polymers 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 229960000074 biopharmaceutical Drugs 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 229930188620 butyrolactone Natural products 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 229920006317 cationic polymer Polymers 0.000 description 1
- 239000012930 cell culture fluid Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000002801 charged material Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 229940044683 chemotherapy drug Drugs 0.000 description 1
- 238000004581 coalescence Methods 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229920006237 degradable polymer Polymers 0.000 description 1
- 239000003405 delayed action preparation Substances 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000000890 drug combination Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 108010048367 enhanced green fluorescent protein Proteins 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 238000001476 gene delivery Methods 0.000 description 1
- 238000001415 gene therapy Methods 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 238000009169 immunotherapy Methods 0.000 description 1
- 210000003292 kidney cell Anatomy 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 229920001427 mPEG Polymers 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000004531 microgranule Substances 0.000 description 1
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 1
- MREZLUJXFNFQIH-UHFFFAOYSA-N n,2-dimethylbut-2-enamide Chemical compound CNC(=O)C(C)=CC MREZLUJXFNFQIH-UHFFFAOYSA-N 0.000 description 1
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 1
- LLYBWQANNKRYST-UHFFFAOYSA-N n-[3-[bis(2-methoxyethyl)amino]-4-methoxyphenyl]acetamide Chemical compound COCCN(CCOC)C1=CC(NC(C)=O)=CC=C1OC LLYBWQANNKRYST-UHFFFAOYSA-N 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 235000010603 pastilles Nutrition 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- 238000010587 phase diagram Methods 0.000 description 1
- 125000004437 phosphorous atom Chemical group 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229960000502 poloxamer Drugs 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 229920002523 polyethylene Glycol 1000 Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000012679 serum free medium Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000003104 tissue culture media Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 229920000428 triblock copolymer Polymers 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Images
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
梳型接枝共聚物 | 水溶液浓度/% | 凝胶温度范围/℃ |
PCL-g-PDMAEMA-1 | 25 | 23~37 |
PCL-g-PDMAEMA-1 | 20 | 25~32 |
PCL-g-PDMAEMA-1 | 30 | 21~39 |
PCL-g-PDMAEMA-2 | -- | -- |
PCL-g-PDMAEMA-3 | 8 | 30~40 |
PCL-g-PDMAEMA-3 | 15 | 26~48 |
PCL-g-PDMAEMA-4 | 20 | 15~45 |
PCL-g-PDMAEMA-5 | 20 | 30~38 |
PCL-g-PDMAEMA-6 | 20 | 25~38 |
PCL-g-PDMAEMA-7 | 15 | 30~43 |
PCL-g-PDMAEMA-8 | -- | -- |
PCL-g-PDMAEMA-9 | 5 | 20~30 |
PCL-g-PDMAEMA-10 | 10 | 18~40 |
PCL-g-PDMAEMA-11 | 3 | 18~42 |
PCL/PLA-g-PDMAEMA | 20 | 23~37 |
PCL/PLGA-g-PDMAEMA | 15 | 30-40 |
PCL/PGA-g-PDMAEMA | 25 | 35-37 |
PCL/PBA-g-PDMAEMA | 20 | 30-36 |
PCL/PPA-g-PDMAEMA | -- | -- |
PCL-g-PIPAA | 20 | 28-40 |
PCL-g-PDMAA/PIPAA(1/1) | 60 | 40-45 |
PCL-g-PDEAA | 8 | 32-41 |
PCL-g-P(DMAEMA/DMAMMA)(1/9) | 20 | 32-40 |
PCL/PPA-g-PDMAEA | 20 | 30-40 |
PCL/PLA-g-PDMAMAP | 20 | 32-40 |
PCL/PLGA-g-PDEAEMA | 25 | 32-38 |
PCL-g-PDEAMMA | 20 | 30-40 |
PCL/PPA-g-PDEAEA | 30 | 32-42 |
PCL/PLA-g-PDEAMA | 25 | 29-38 |
PCL/PGA-g-DMAEMA/PIPMAA(8/2) | 20 | 28-40 |
PCL/PLGA-g-PDMMAA | 20 | 27-42 |
PCL-g-PDEMAA | -- | -- |
PCL-g-PDMAEMA/PEGA5000 | 20 | 25-42 |
PCL-g-PDMAEMA/PEGA1000 | 50 | 30-35 |
PCL-g-PDMAEMA/PEGA10000 | 5 | 30-40 |
PCL-g-PDMAEMA/PEGA2000 | 20 | 28-45 |
PCL-g-PDMAEMA/PEG MA2000 | 20 | 25-39 |
PCL-g-PDMAEMA/PEG MA5000 | 15 | 25-45 |
PCL/PDLLA-g-PDMAEMA/PEGA400 | 20 | 23-37 |
PCL/PLGA-g-PDMAEMA/PEGMA800 | 20 | 30-39 |
PCL/PGA-g-PDMAEMA/PEGA1000 | 20 | 32-38 |
PCL/PBA-g-PDMAEMA/PEGA200 | 20 | 30-36 |
PCL/PPA-g-PDMAEMA/PEGMA2000 | 25 | 30-42 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009101432340A CN101684174B (zh) | 2008-07-09 | 2009-05-21 | 两亲性可生物降解聚酯梳型接枝共聚物及其温敏原位凝胶体系 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200810053792.3 | 2008-07-09 | ||
CN200810053792 | 2008-07-09 | ||
CN2009101432340A CN101684174B (zh) | 2008-07-09 | 2009-05-21 | 两亲性可生物降解聚酯梳型接枝共聚物及其温敏原位凝胶体系 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101684174A true CN101684174A (zh) | 2010-03-31 |
CN101684174B CN101684174B (zh) | 2012-04-25 |
Family
ID=42047568
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009101432340A Expired - Fee Related CN101684174B (zh) | 2008-07-09 | 2009-05-21 | 两亲性可生物降解聚酯梳型接枝共聚物及其温敏原位凝胶体系 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101684174B (zh) |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101880397A (zh) * | 2010-07-02 | 2010-11-10 | 中国科学院长春应用化学研究所 | 一种交联聚合物及其制备方法 |
CN102477439A (zh) * | 2010-11-22 | 2012-05-30 | 苏州瑞博生物技术有限公司 | 三元复合物和含有三元复合物的液体及制备方法与应用 |
CN102675676A (zh) * | 2011-03-17 | 2012-09-19 | 中国医学科学院肿瘤研究所 | 一种PCL-g-PDMAEMA/明胶复合材料及其制备方法 |
CN102675678A (zh) * | 2011-03-17 | 2012-09-19 | 中国医学科学院肿瘤研究所 | 一种PCL-g-PGMA/明胶复合材料及其制备方法 |
CN102675677A (zh) * | 2011-03-17 | 2012-09-19 | 中国医学科学院肿瘤研究所 | PCL-g-PGMA/明胶复合材料在细胞转染中的应用 |
CN102690843A (zh) * | 2012-05-23 | 2012-09-26 | 天津大学 | 一种阳离子聚合物基因载体及制备方法 |
CN103255174A (zh) * | 2013-05-02 | 2013-08-21 | 天津大学 | 以聚乙二醇接枝的透明质酸为外层的三元复合物及三元复合物的液体与应用 |
CN106632819A (zh) * | 2016-12-26 | 2017-05-10 | 中国石油大学(华东) | 一种具有挤压和开关效应的纳米药物载体的制备方法 |
CN108047455A (zh) * | 2018-02-09 | 2018-05-18 | 中国人民解放军陆军军医大学 | 用于抗原载体的两亲性超支化聚合物及其制备方法和应用 |
CN108329483A (zh) * | 2018-02-09 | 2018-07-27 | 中国人民解放军陆军军医大学 | 两亲性超支化聚合物及其制备方法和应用 |
CN109608648A (zh) * | 2018-12-06 | 2019-04-12 | 太原理工大学 | 一种具有温度响应性能的聚酰亚胺材料及其制备方法 |
CN111690111A (zh) * | 2020-07-30 | 2020-09-22 | 中国科学院兰州化学物理研究所 | 一种梳型聚合物及其制备方法和应用 |
CN114349944A (zh) * | 2020-10-13 | 2022-04-15 | 中石化南京化工研究院有限公司 | 一种聚己内酯嵌段共聚物及其制备方法 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2021347147A1 (en) * | 2020-09-22 | 2023-05-18 | Barinthus Biotherapeutics North America, Inc. | Compositions and methods of manufacturing amphiphilic block copolymers that form nanoparticles in situ |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU752942B2 (en) * | 1998-04-13 | 2002-10-03 | Massachusetts Institute Of Technology | Comb copolymers for regulating cell-surface interactions |
CN101177487B (zh) * | 2006-11-08 | 2011-12-07 | 天津大学 | 温敏性可生物降解聚酸酐共聚物及其水凝胶体系和应用 |
-
2009
- 2009-05-21 CN CN2009101432340A patent/CN101684174B/zh not_active Expired - Fee Related
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101880397A (zh) * | 2010-07-02 | 2010-11-10 | 中国科学院长春应用化学研究所 | 一种交联聚合物及其制备方法 |
CN101880397B (zh) * | 2010-07-02 | 2012-06-27 | 中国科学院长春应用化学研究所 | 一种交联聚合物及其制备方法 |
CN102477439A (zh) * | 2010-11-22 | 2012-05-30 | 苏州瑞博生物技术有限公司 | 三元复合物和含有三元复合物的液体及制备方法与应用 |
CN102675677B (zh) * | 2011-03-17 | 2014-04-16 | 中国医学科学院肿瘤研究所 | PCL-g-PGMA/明胶复合材料在细胞转染中的应用 |
CN102675678A (zh) * | 2011-03-17 | 2012-09-19 | 中国医学科学院肿瘤研究所 | 一种PCL-g-PGMA/明胶复合材料及其制备方法 |
CN102675677A (zh) * | 2011-03-17 | 2012-09-19 | 中国医学科学院肿瘤研究所 | PCL-g-PGMA/明胶复合材料在细胞转染中的应用 |
CN102675676A (zh) * | 2011-03-17 | 2012-09-19 | 中国医学科学院肿瘤研究所 | 一种PCL-g-PDMAEMA/明胶复合材料及其制备方法 |
CN102675678B (zh) * | 2011-03-17 | 2014-04-16 | 中国医学科学院肿瘤研究所 | 一种PCL-g-PGMA/明胶复合材料及其制备方法 |
CN102690843A (zh) * | 2012-05-23 | 2012-09-26 | 天津大学 | 一种阳离子聚合物基因载体及制备方法 |
CN103255174A (zh) * | 2013-05-02 | 2013-08-21 | 天津大学 | 以聚乙二醇接枝的透明质酸为外层的三元复合物及三元复合物的液体与应用 |
CN106632819A (zh) * | 2016-12-26 | 2017-05-10 | 中国石油大学(华东) | 一种具有挤压和开关效应的纳米药物载体的制备方法 |
CN106632819B (zh) * | 2016-12-26 | 2018-10-12 | 中国石油大学(华东) | 一种具有挤压和开关效应的纳米药物载体的制备方法 |
CN108047455A (zh) * | 2018-02-09 | 2018-05-18 | 中国人民解放军陆军军医大学 | 用于抗原载体的两亲性超支化聚合物及其制备方法和应用 |
CN108329483A (zh) * | 2018-02-09 | 2018-07-27 | 中国人民解放军陆军军医大学 | 两亲性超支化聚合物及其制备方法和应用 |
CN108047455B (zh) * | 2018-02-09 | 2020-12-25 | 中国人民解放军陆军军医大学 | 用于抗原载体的两亲性超支化聚合物及其制备方法和应用 |
CN109608648A (zh) * | 2018-12-06 | 2019-04-12 | 太原理工大学 | 一种具有温度响应性能的聚酰亚胺材料及其制备方法 |
CN111690111A (zh) * | 2020-07-30 | 2020-09-22 | 中国科学院兰州化学物理研究所 | 一种梳型聚合物及其制备方法和应用 |
CN114349944A (zh) * | 2020-10-13 | 2022-04-15 | 中石化南京化工研究院有限公司 | 一种聚己内酯嵌段共聚物及其制备方法 |
CN114349944B (zh) * | 2020-10-13 | 2023-12-05 | 中石化南京化工研究院有限公司 | 一种聚己内酯嵌段共聚物及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN101684174B (zh) | 2012-04-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101684174B (zh) | 两亲性可生物降解聚酯梳型接枝共聚物及其温敏原位凝胶体系 | |
CN102030871B (zh) | 聚乙二醇嵌段可生物降解聚酯梳型接枝共聚物及其制备方法和应用 | |
CN102030898B (zh) | Abc型两亲性生物降解聚酯三嵌段共聚物及制备方法和应用 | |
Li et al. | Towards the development of polycaprolactone based amphiphilic block copolymers: molecular design, self-assembly and biomedical applications | |
CN103254442B (zh) | 二硫键键接的聚酯梳型接枝共聚物及其制备方法和应用 | |
Singh et al. | In situ gelling pH-and temperature-sensitive biodegradable block copolymer hydrogels for drug delivery | |
Chen et al. | pH-dependent, thermosensitive polymeric nanocarriers for drug delivery to solid tumors | |
Garripelli et al. | A novel thermosensitive polymer with pH-dependent degradation for drug delivery | |
Tiwari et al. | Derivatization approaches and applications of pullulan | |
CN101864065B (zh) | 含环醚侧基的可生物降解两亲性嵌段共聚物及其制备方法和应用 | |
Ganji et al. | Chitosan–g-PLGA copolymer as a thermosensitive membrane | |
CN100427144C (zh) | 一种可降解的温敏性物理水凝胶及其制备方法 | |
CN101787119A (zh) | 一种具有肿瘤组织pH响应性的聚合物及其胶束 | |
CN104031261B (zh) | 温敏性共聚物及其水凝胶体系 | |
Alper Isoglu et al. | Advances in micelle-based drug delivery: cross-linked systems | |
Gu et al. | Sustained interferon-γ delivery from a photocrosslinked biodegradable elastomer | |
CN101489574A (zh) | 内包生理活性多肽或蛋白质的高分子聚合物胶束及其制造方法 | |
CN101177487B (zh) | 温敏性可生物降解聚酸酐共聚物及其水凝胶体系和应用 | |
CN106317416A (zh) | 一种双pH响应的两亲性共聚物及其制备方法和用途 | |
Wang et al. | Synthesis of a chemically-crosslinked thermo-sensitive hydrogel film and in situ encapsulation of model protein drugs | |
CN101787120B (zh) | 三嵌段聚氨基酸及其水凝胶 | |
CN1446833A (zh) | 一种温敏性可降解微凝胶及其制备方法 | |
Sang et al. | Preparation and controlled drug release ability of the poly [N-isopropylacryamide-co-allyl poly (ethylene glycol)]-b-poly (γ-benzyl-l-glutamate) polymeric micelles | |
CN105030672A (zh) | 一种温度响应性的立构复合聚乳酸共聚物载药胶束的制备方法 | |
CN101880381B (zh) | 聚乙二醇1000维生素e琥珀酸酯修饰的嵌段共聚物及其制备方法与应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20201130 Address after: No. 288, Changjiang West Road, hi tech Zone (former Hai'an town), Hai'an City, Nantong City, Jiangsu Province, 226600 Patentee after: Jiangsu Qingcai Intelligent Manufacturing Co.,Ltd. Address before: 06-01-45, block B, Baoneng entrepreneurship center, Xiyuzhuang street, Hongqiao District, Tianjin Patentee before: Tianjin Kerun productivity promotion Co.,Ltd. Effective date of registration: 20201130 Address after: 06-01-45, block B, Baoneng entrepreneurship center, Xiyuzhuang street, Hongqiao District, Tianjin Patentee after: Tianjin Kerun productivity promotion Co.,Ltd. Address before: 300072 Tianjin City, Nankai District Wei Jin Road No. 92 Patentee before: Tianjin University |
|
TR01 | Transfer of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120425 |